SecurityOTIC / Otonomy, Inc. (68906L105)
President & CEOWeber David Allen
IndustryPharmaceutical Preparations
Institutional Owners85
Institutional Shares22,595,176 - 73.89%
Common Shares Outstanding30,577,526 shares (as of 2018-03-31)
Institutional Value$ 786,105,000 USD

Institutional Stock Ownership and Shareholders()

OTIC / Otonomy, Inc. Institutional Ownership

Otonomy, Inc. (NASDAQ:OTIC) has 85 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 22,595,176 shares. Largest shareholders include Wellington Management Group LLP, TPG Group Holdings (SBS) Advisors, Inc., BlackRock Inc., First Manhattan Co, BlackRock Fund Advisors, Vanguard Group Inc, Dimensional Fund Advisors Lp, Renaissance Technologies LLC, D. E. Shaw & Co., Inc., and 683 Capital Management, LLC.
Otonomy, Inc. (NASDAQ:OTIC) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/otic"><img src="https://images.fintel.io/us-otic-so.png" alt="OTIC / Otonomy, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 346,468 117,058 -66.21 1,923 492 -74.41
2017-01-18 13F-HR WALL STREET ASSOCIATES 101,600 0 -100.00 1,848 0 -100.00
2018-05-10 13F-HR First Personal Financial Services 1,177 697 -40.78 7 3 -57.14
2018-05-15 13F-HR Invesco Ltd. 0 36,226 0 152
2018-05-15 13F-HR A.R.T. Advisors, LLC 126,626 65,526 -48.25 702 275 -60.83
2018-05-14 13F-HR DLD Asset Management, LP 510,000 0 -100.00 2,831 0 -100.00
2018-05-14 13F-HR BOGLE INVESTMENT MANAGEMENT L P /DE/ 362,086 92,686 -74.40 2,009 389 -80.64
2018-05-14 13F-HR Hudson Bay Capital Management LP 200,000 174,905 -12.55 1,110 735 -33.78
2018-05-14 13F-HR TEACHERS ADVISORS INC 59,416 59,416 0.00 330 250 -24.24
2018-04-26 13F-HR SIMPLEX TRADING, LLC 25,472 0 -100.00 141 0 -100.00
2017-02-10 13F-HR BlackRock Advisors LLC 221,469 237,724 7.34 4,028 3,779 -6.18
2018-05-02 13F-HR RHUMBLINE ADVISERS 28,661 26,886 -6.19 159 113 -28.93
2018-05-15 13F-HR TPG Group Holdings (SBS) Advisors, Inc. 2,159,335 2,159,335 0.00 11,984 9,069 -24.32
2018-05-11 13F-HR MACQUARIE GROUP LTD 1,800 0 -100.00 10 0 -100.00
2018-05-08 13F-HR Lakeview Capital Partners, LLC 26,000 33,800 30.00 144 142 -1.39
2018-05-15 13F-HR Sofinnova Ventures Inc 98,624 414
2018-05-08 13F-HR Tyers Asset Management LLC 27,188 2,856 -89.50 151 12 -92.05
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 250,542 247,622 -1.17 1,391 1,040 -25.23
2017-08-11 13F-HR FT Options LLC 83,747 58,407 -30.26 1,026 1,101 7.31
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 30,300 30,300 0.00 168 127 -24.40
2018-05-09 13F-HR NORTHERN TRUST CORP 319,105 318,868 -0.07 1,771 1,340 -24.34
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 756 391 -48.28 4 2 -50.00
2017-05-15 13F-HR Amici Capital, LLC 237,885 0 -100.00 3,782 0 -100.00
2018-05-07 13F-HR MUFG Americas Holdings Corp 301 0 -100.00 2 0 -100.00
2018-05-10 13F-HR JP Morgan Chase & Co 6,099 265,771 4,257.62 34 1,116 3,182.35
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 13,759 4,000 -70.93 76 17 -77.63
2018-05-16 13F-HR ASSETMARK, INC 73 0 -100.00 0 0
2018-04-20 13F-HR FIRST MANHATTAN CO 1,902,000 1,902,000 0.00 10,556 7,988 -24.33
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 558,777 558,057 -0.13 10,164 8,873 -12.70
2018-05-15 13F-HR CREDIT SUISSE AG/ 0 10,789 0 44
2018-05-15 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 0 102,235 0 429
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 2,475 2,475 0.00 14 10 -28.57
2017-08-11 13F-HR FT Options LLC Put 15,000 56,300 275.33 28 113 303.57
2017-01-13 13F-HR MetLife Securities, Inc 400 0 -100.00 7 0 -100.00
2018-05-14 13F-HR Renaissance Technologies LLC 737,650 1,016,700 37.83 4,094 4,270 4.30
2018-05-15 13F-HR DEUTSCHE BANK AG\ 351,180 250,600 -28.64 1,947 1,051 -46.02
2018-05-15 13F-HR BALYASNY ASSET MANAGEMENT LLC 46,100 134,147 190.99 256 563 119.92
2018-05-15 13F-HR STATE STREET CORP 438,891 458,477 4.46 2,435 1,926 -20.90
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 8,479 6,129 -27.72 47,058 25,742 -45.30
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 58,338 18,875 -67.65 324 79 -75.62
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Call 17,600 0 -100.00 98 0 -100.00
2017-02-10 13F-HR BlackRock Investment Management, LLC 113,318 111,549 -1.56 2,061 1,774 -13.93
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 37 0 -100.00 0 0
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 51,323 68,706 33.87 285 289 1.40
2018-05-17 13F-HR Legal & General Group Plc 6,348 4,170 -34.31 35 18 -48.57
2018-05-10 13F-HR Flinton Capital Management LLC 33,014 3,468 -89.50 183 15 -91.80
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 43,800 17,900 -59.13 243 75 -69.14
2018-05-14 13F-HR Virtu Financial LLC 24,772 11,891 -52.00 137 50 -63.50
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 877,214 1,124,019 28.14 4,869 4,721 -3.04
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 800 3
2018-05-14 13F-HR DRW Securities, LLC 15,000 15,000 0.00 83 63 -24.10
2018-05-25 13F-HR/A Worth Venture Partners, LLC 53,760 0 -100.00 299 0 -100.00
2017-08-11 13F-HR FT Options LLC Call 1,700 33,500 1,870.59 3 106 3,433.33
2018-05-08 13F-HR Neuburgh Advisers LLC 21,362 2,244 -89.50 119 9 -92.44
2018-05-11 13F-HR Cutler Group LP 11,212 1,200 -89.30 62 5 -91.94
2018-05-15 13F-HR J. Goldman & Co LP 273,000 156,000 -42.86 1,515 655 -56.77
2018-05-11 13F-HR CITADEL ADVISORS LLC 100,736 423
2018-05-15 13F-HR 683 Capital Management, LLC 550,000 650,000 18.18 3,053 2,730 -10.58
2018-05-03 13F-HR Trexquant Investment LP 0 31,153 0 131
2018-05-10 13F-HR Elkfork Partners LLC 27,188 0 -100.00 151 0 -100.00
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 18,779 18,834 0.29 104 79 -24.04
2017-02-10 13F-HR BlackRock Group LTD 6,089 6,635 8.97 111 105 -5.41
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 15,900 0 -100.00 88 0 -100.00
2018-05-15 13F-HR Crestline Management, LP 264,648 297,559 12.44 1,469 1,250 -14.91
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 46,251 43,567 -5.80 257 183 -28.79
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 2,499 2,499 0.00 14 10 -28.57
2018-05-15 13F-HR NEXTHERA CAPITAL LP 602,748 0 -100.00 3,345 0 -100.00
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 0 3,525 0 15
2018-05-15 13F-HR Voya Investment Management LLC 12,606 12,606 0.00 70 53 -24.29
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 35,996 48,712 35.33 200 204 2.00
2018-05-15 13F-HR D. E. Shaw & Co., Inc. 817,296 817,208 -0.01 4,536 3,433 -24.32
2018-05-15 13F-HR New Leaf Venture Partners, L.L.C. 109,825 0 -100.00 610 0 -100.00
2018-05-15 13F-HR Wellington Management Group LLP 3,928,918 3,680,771 -6.32 21,806 15,459 -29.11
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 1,515 518 -65.81 8 2 -75.00
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 18,991 18,021 -5.11 105 76 -27.62
2018-05-15 13F-HR JANE STREET GROUP, LLC 11,463 0 -100.00 64 0 -100.00
2018-05-15 13F-HR AQR CAPITAL MANAGEMENT LLC 493,350 119,854 -75.71 2,738 503 -81.63
2018-05-15 13F-HR BARCLAYS PLC 145,904 144,379 -1.05 809 606 -25.09
2018-05-14 13F-HR PURA VIDA INVESTMENTS, LLC 404,742 152,486 -62.33 2,246,318 640,441 -71.49
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 30,500 30,500 0.00 169 128 -24.26
2018-05-11 13F-HR CITIGROUP INC 3,101 7,643 146.47 17 32 88.24
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 208,652 212,436 1.81 1,158 892 -22.97
2018-05-08 13F-HR TIVERTON ASSET MANAGEMENT LLC 64,917 6,983 -89.24 360 29 -91.94
2018-05-11 13F-HR Russell Investments Group, Ltd. 0 10,100 0 42
2018-05-14 13F-HR Itau Unibanco Holding S.A. 961 3,310 244.43 5 14 180.00
2018-07-18 13F-HR REILLY FINANCIAL ADVISORS, LLC 700 700 0.00 3 3 0.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 5,721 2,857 -50.06 32 12 -62.50
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 410,300 48,600 -88.16 2,277 204 -91.04
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 4,284 0 -100.00 24 0 -100.00
2018-05-11 13F-HR Cutler Group LP Call 1,700 7,800 358.82 2 0 -100.00
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 80,900 74,900 -7.42 449 315 -29.84
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 140,315 103,927 -25.93 779 436 -44.03
2018-05-07 13F-HR STATE OF WISCONSIN INVESTMENT BOARD 19,000 19,000 0.00 105 80 -23.81
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 109,521 167,557 52.99 608 704 15.79
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 22,377 11,118 -50.32 125 47 -62.40
2018-05-15 13F-HR Bank of New York Mellon Corp 635,160 604,100 -4.89 3,524 2,537 -28.01
2018-05-09 13F-HR Meadow Creek Investment Management LLC 15,536 86
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 110,872 114,616 3.38 616 482 -21.75
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 14,435 14,838 2.79 80 62 -22.50
2018-05-14 13F-HR MORGAN STANLEY 59,328 109,912 85.26 329 462 40.43
2018-05-15 13F-HR Squarepoint Ops LLC 45,644 0 -100.00 253 0 -100.00
2018-05-09 13F-HR BlackRock Inc. 2,051,616 2,070,337 0.91 11,387 8,696 -23.63
2018-05-14 13F-HR Connor, Clark & Lunn Investment Management Ltd. 11,969 33,869 182.97 66 142 115.15
2018-05-15 13F-HR HIGHLAND CAPITAL MANAGEMENT LP 40,000 0 -100.00 222 0 -100.00
2017-02-10 13F-HR BlackRock Fund Advisors 1,070,837 1,207,139 12.73 19,479 19,194 -1.46
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 2,508 2,508 0.00 11 10 -9.09
2018-05-15 13F-HR Man Group plc 382,600 1,607
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 5,500 3,000 -45.45 31 13 -58.06
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 87,829 100,736 14.70 487 423 -13.14
2018-05-15 13F-HR Marshall Wace North America L.P. 124,422 18,606 -85.05 691 78 -88.71
2018-05-15 13F-HR VANGUARD GROUP INC 1,092,435 1,129,656 3.41 6,063 4,744 -21.75
OTIC : Otonomy Stock Analysis and Research Report

2017-11-08 - Asif

Otonomy is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear. OTIPRIOâ (ciprofloxacin otic suspension) is approved in the United States for use during tympanostomy tube placement (TTP) surgery in pediatric patients, has achieved positive pivotal trial results in patients with acute otitis externa (AOE), and has completed a successful Phase 2 trial in patients with acute otitis media with tubes (AOMT). OTO-104 is a steroid in development for the treatment of Ménière’s disease and other severe balance and hearing disorders. Two Phase 3 trials in Ménière’s disease patients are underway with results expected during the second half of 2017, and a Phase 2 trial has been initiated in patients at risk for cisplatin-induced hearing loss. OTO-311 is a N-Methyl-D-Aspartate (NMDA) receptor antagonist for the treatment of tinnitus that has completed a Phase 1 clinical safety trial with a Phase 2 trial expect...

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Otonomy (OTIC) Sees Hammer Chart Pattern: Time to Buy?

2018-04-09 zacks
Otonomy, Inc. (OTIC - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because OTIC recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom. (112-0)

CUSIP: 68906L105